Through the inhibition of the TLR4/NF-κB pathway, the secretion of TNF-α, IL-6, and IL-1β decreases, and the injury to the brain due to intracerebral hemorrhage can be attenuated [50, 51]. The gene discussed is IL1B; the disease is intracerebral hemorrhage.